Exogenous nitric oxide stimulated collagen type I expression and TGF-β1 production in keloid fibroblasts by a cGMP-dependent manner

Yi Chiang Hsu, Michael Hsiao, Yie W. Chien, Woan Ruoh Lee

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Keloids arise from the aberrant wound healing process and nitric oxide (NO) plays an important role in the inflammation stage of wound healing. In order to better define the potential effect of NO/cGMP signal pathway in the keloid pathogenesis, the enhancing effect of exogenous NO (released from NO donor) on collagen expression in the keloid fibroblast (KF) as well as on the induction of collagen type I protein and TGF-β1 expression in the KF were studied in this investigation. The DETA NONOate, an NO donor, was added to the KF, as the exogenous NO, to release NO in the culture medium. The expression of collagens was then determined by assaying the total soluble collagens and collagen type I in the KF. The cellular concentration of cGMP was measured by EIA in the KF. Exogenous NO was found to enhance the expression of collagens and elevate the cellular levels of cGMP. Moreover, to evaluate the effect of the elevated cellular cGMP levels on the expression of collagen and TGF-β1, both cGMP and TGF-β1 were measured by ELISA. The inhibitors for phosphodiesterase (PDE), such as IBMX (3-isobutyl-1-methylxanthine), Vinpocetine, EHNA, Milrinone and Zapriast, which have been reported to reduce the ability of PDE and subsequently produce an increase of cellular cGMP, induce the production of autocrine TGF-β1 as well as the synthesis of collagen in the KF. In this investigation, the inhibition of the PDE enzyme activity was observed to enhance the effect on the collagen synthesis, and was induced by exogenous NO. Taken together, these results have suggested that the NO/cGMP pathway could positively influence the progression of keloid formation, via the TGF-β1 expression in the KF.

Original languageEnglish
Pages (from-to)258-265
Number of pages8
JournalNitric Oxide - Biology and Chemistry
Volume16
Issue number2
DOIs
Publication statusPublished - Mar 2007

Fingerprint

Keloid
Fibroblasts
Collagen Type I
Nitric Oxide
Collagen
Nitric Oxide Donors
Phosphoric Diester Hydrolases
vinpocetine
Wound Healing
Milrinone
Enzyme inhibition
1-Methyl-3-isobutylxanthine
Phosphodiesterase Inhibitors
Enzyme activity
Culture Media
Signal Transduction
Enzyme-Linked Immunosorbent Assay
Inflammation

Keywords

  • Cyclic guanosine monophosphate (cGMP)
  • Nitric oxide (NO)
  • Phosphodiesterase (PDE)
  • Transforming growth factor-β1 (TGF-β1)

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Exogenous nitric oxide stimulated collagen type I expression and TGF-β1 production in keloid fibroblasts by a cGMP-dependent manner. / Hsu, Yi Chiang; Hsiao, Michael; Chien, Yie W.; Lee, Woan Ruoh.

In: Nitric Oxide - Biology and Chemistry, Vol. 16, No. 2, 03.2007, p. 258-265.

Research output: Contribution to journalArticle

@article{2258ac52df974f7a9d96c6b6ecf32bed,
title = "Exogenous nitric oxide stimulated collagen type I expression and TGF-β1 production in keloid fibroblasts by a cGMP-dependent manner",
abstract = "Keloids arise from the aberrant wound healing process and nitric oxide (NO) plays an important role in the inflammation stage of wound healing. In order to better define the potential effect of NO/cGMP signal pathway in the keloid pathogenesis, the enhancing effect of exogenous NO (released from NO donor) on collagen expression in the keloid fibroblast (KF) as well as on the induction of collagen type I protein and TGF-β1 expression in the KF were studied in this investigation. The DETA NONOate, an NO donor, was added to the KF, as the exogenous NO, to release NO in the culture medium. The expression of collagens was then determined by assaying the total soluble collagens and collagen type I in the KF. The cellular concentration of cGMP was measured by EIA in the KF. Exogenous NO was found to enhance the expression of collagens and elevate the cellular levels of cGMP. Moreover, to evaluate the effect of the elevated cellular cGMP levels on the expression of collagen and TGF-β1, both cGMP and TGF-β1 were measured by ELISA. The inhibitors for phosphodiesterase (PDE), such as IBMX (3-isobutyl-1-methylxanthine), Vinpocetine, EHNA, Milrinone and Zapriast, which have been reported to reduce the ability of PDE and subsequently produce an increase of cellular cGMP, induce the production of autocrine TGF-β1 as well as the synthesis of collagen in the KF. In this investigation, the inhibition of the PDE enzyme activity was observed to enhance the effect on the collagen synthesis, and was induced by exogenous NO. Taken together, these results have suggested that the NO/cGMP pathway could positively influence the progression of keloid formation, via the TGF-β1 expression in the KF.",
keywords = "Cyclic guanosine monophosphate (cGMP), Nitric oxide (NO), Phosphodiesterase (PDE), Transforming growth factor-β1 (TGF-β1)",
author = "Hsu, {Yi Chiang} and Michael Hsiao and Chien, {Yie W.} and Lee, {Woan Ruoh}",
year = "2007",
month = "3",
doi = "10.1016/j.niox.2006.09.002",
language = "English",
volume = "16",
pages = "258--265",
journal = "Nitric Oxide - Biology and Chemistry",
issn = "1089-8603",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Exogenous nitric oxide stimulated collagen type I expression and TGF-β1 production in keloid fibroblasts by a cGMP-dependent manner

AU - Hsu, Yi Chiang

AU - Hsiao, Michael

AU - Chien, Yie W.

AU - Lee, Woan Ruoh

PY - 2007/3

Y1 - 2007/3

N2 - Keloids arise from the aberrant wound healing process and nitric oxide (NO) plays an important role in the inflammation stage of wound healing. In order to better define the potential effect of NO/cGMP signal pathway in the keloid pathogenesis, the enhancing effect of exogenous NO (released from NO donor) on collagen expression in the keloid fibroblast (KF) as well as on the induction of collagen type I protein and TGF-β1 expression in the KF were studied in this investigation. The DETA NONOate, an NO donor, was added to the KF, as the exogenous NO, to release NO in the culture medium. The expression of collagens was then determined by assaying the total soluble collagens and collagen type I in the KF. The cellular concentration of cGMP was measured by EIA in the KF. Exogenous NO was found to enhance the expression of collagens and elevate the cellular levels of cGMP. Moreover, to evaluate the effect of the elevated cellular cGMP levels on the expression of collagen and TGF-β1, both cGMP and TGF-β1 were measured by ELISA. The inhibitors for phosphodiesterase (PDE), such as IBMX (3-isobutyl-1-methylxanthine), Vinpocetine, EHNA, Milrinone and Zapriast, which have been reported to reduce the ability of PDE and subsequently produce an increase of cellular cGMP, induce the production of autocrine TGF-β1 as well as the synthesis of collagen in the KF. In this investigation, the inhibition of the PDE enzyme activity was observed to enhance the effect on the collagen synthesis, and was induced by exogenous NO. Taken together, these results have suggested that the NO/cGMP pathway could positively influence the progression of keloid formation, via the TGF-β1 expression in the KF.

AB - Keloids arise from the aberrant wound healing process and nitric oxide (NO) plays an important role in the inflammation stage of wound healing. In order to better define the potential effect of NO/cGMP signal pathway in the keloid pathogenesis, the enhancing effect of exogenous NO (released from NO donor) on collagen expression in the keloid fibroblast (KF) as well as on the induction of collagen type I protein and TGF-β1 expression in the KF were studied in this investigation. The DETA NONOate, an NO donor, was added to the KF, as the exogenous NO, to release NO in the culture medium. The expression of collagens was then determined by assaying the total soluble collagens and collagen type I in the KF. The cellular concentration of cGMP was measured by EIA in the KF. Exogenous NO was found to enhance the expression of collagens and elevate the cellular levels of cGMP. Moreover, to evaluate the effect of the elevated cellular cGMP levels on the expression of collagen and TGF-β1, both cGMP and TGF-β1 were measured by ELISA. The inhibitors for phosphodiesterase (PDE), such as IBMX (3-isobutyl-1-methylxanthine), Vinpocetine, EHNA, Milrinone and Zapriast, which have been reported to reduce the ability of PDE and subsequently produce an increase of cellular cGMP, induce the production of autocrine TGF-β1 as well as the synthesis of collagen in the KF. In this investigation, the inhibition of the PDE enzyme activity was observed to enhance the effect on the collagen synthesis, and was induced by exogenous NO. Taken together, these results have suggested that the NO/cGMP pathway could positively influence the progression of keloid formation, via the TGF-β1 expression in the KF.

KW - Cyclic guanosine monophosphate (cGMP)

KW - Nitric oxide (NO)

KW - Phosphodiesterase (PDE)

KW - Transforming growth factor-β1 (TGF-β1)

UR - http://www.scopus.com/inward/record.url?scp=33845687009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845687009&partnerID=8YFLogxK

U2 - 10.1016/j.niox.2006.09.002

DO - 10.1016/j.niox.2006.09.002

M3 - Article

C2 - 17052928

AN - SCOPUS:33845687009

VL - 16

SP - 258

EP - 265

JO - Nitric Oxide - Biology and Chemistry

JF - Nitric Oxide - Biology and Chemistry

SN - 1089-8603

IS - 2

ER -